Abiopharma

New Form 3 - AerCap Holdings N.V. <b>Filed:</b> 2026-04-27 <b>AccNo:</b> 0000950157-26-000551 <b>Size:</b> 2 KB

(99% Neutral) U.S. GOLD CORP. (USAU) Files Form 8-K

Robertson Aaron A. 🟡 adjusted position in 1.1M shares of Commercial Bancgroup, Inc. (CBK) Transaction Date: Mar 03, 2026 | Filing ID: 000291

📋 Atlas Venture Opportunity Fund II, LP (Shareholder) plans to sell 46K shares of Dyne Therapeutics, Inc. (at $18.26 each, total $835K) Filed: Apr 27, 2026 | ID: 027569

Director Fernandez Antonio F. 🟢 acquired 16.9K shares of Utz Brands, Inc. (UTZ) Transaction Date: Apr 23, 2026 | Filing ID: 027567

📋 Atlas Venture Opportunity Fund I, LP (Shareholder) plans to sell 36K shares of Dyne Therapeutics, Inc. (at $18.26 each, total $656K) Filed: Apr 27, 2026 | ID: 027564

Director Lissette Dylan 🟢 acquired 16.9K shares of Utz Brands, Inc. (UTZ) Transaction Date: Apr 23, 2026 | Filing ID: 027563

Matly David 🟢 acquired 50.0K shares (1 derivative) of Inhibrx Biosciences, Inc. (INBX) at $129.06 ($6.5M) Transaction Date: Apr 24, 2026 | Filing ID: 000002

📋 Atlas Venture Fund XI, LP (Shareholder) plans to sell 91K shares of Dyne Therapeutics, Inc. (at $18.26 each, total $1.7M) Filed: Apr 27, 2026 | ID: 027562

Fleming Abigail S 🔴 sold 205 shares of Lineage, Inc. (LINE) at $35.55 Transaction Date: Apr 24, 2026 | Filing ID: 000006